Skip to main content
Top
Published in: Abdominal Radiology 1/2017

01-01-2017

Value of pelvis CT during follow-up of patients with pancreatic adenocarcinoma

Authors: Jason J. Bailey, James H. Ellis, Matthew S. Davenport, Richard H. Cohan, Bin Nan, Aishwarya Parameswaran, Lin Hsu, Vaibhav Sahai, Isaac R. Francis

Published in: Abdominal Radiology | Issue 1/2017

Login to get access

Abstract

Purpose

The purpose of this study was to determine the frequency in which the pelvis component of an abdominopelvic CT provides information that would influence clinical management in two separate groups of patients: those with previously resected pancreatic ductal adenocarcinoma (PDA) and those with locally advanced unresectable PDA.

Methods

This institutional review-board approved HIPAA compliant retrospective study with waived informed consent included 247 subjects with histologically proven PDA, including 153 subjects post-pancreaticoduodenectomy and 94 subjects with locally advanced unresectable disease. Imaging reports interpreted between January 2005 and December 2013 were obtained from our institution’s Radiology Information System by searching a Cancer Registry database of PDA patients separately for the words “whipple” and “unresectable.” CT findings were separated by location in the abdomen or pelvis, and subsequently reviewed and graded for their likelihood of representing metastatic disease. The probability of pelvic CT influencing clinical management—i.e., of finding isolated pelvic metastatic disease—was determined using 95% binomial proportion confidence intervals for both the post-pancreaticoduodenectomy and locally advanced unresectable groups.

Results

No subjects who had undergone pancreaticoduodenectomy had an isolated pelvic metastasis on follow-up imaging (0%; 95% CI 0–2.38, p = 0.0004); 33 had metastatic disease in the abdomen, and 120 had no or equivocal evidence of abdominopelvic metastatic disease. One subject with locally advanced unresectable PDA had a possible isolated pelvic metastasis on follow-up imaging (1.1%; 95% CI 0.03–5.79, p = 0.048); 20 had metastatic disease in the abdomen, and 73 had no or equivocal evidence of abdominopelvic metastatic disease.

Conclusion

Isolated pelvic metastatic disease rarely occurs in patients with PDA who have had prior pancreaticoduodenectomy or have a locally advanced unresectable primary tumor, suggesting routine pelvic CT in follow-up imaging of these patients may not be necessary.
Footnotes
1
Values were obtained using the physician fee schedule search provided by cms.gov and reflect fees based on both technical and diagnostic fees using the “Global Service” prices based on a national payment amount for Medicare-enrolled providers for procedure codes 74177 and 74160.
 
2
See footnote 1
 
Literature
3.
go back to reference Yachida S, Iacobuzio-Donahue CA (2009) The pathology and genetics of metastatic pancreatic cancer. Arch Pathol Lab Med 133(3):413–422PubMed Yachida S, Iacobuzio-Donahue CA (2009) The pathology and genetics of metastatic pancreatic cancer. Arch Pathol Lab Med 133(3):413–422PubMed
4.
go back to reference Disibio G, French SW (2008) Metastatic patterns of cancers: results from a large autopsy study. Arch Pathol Lab Med 132(6):931–939PubMed Disibio G, French SW (2008) Metastatic patterns of cancers: results from a large autopsy study. Arch Pathol Lab Med 132(6):931–939PubMed
5.
go back to reference Yeo CJ, Abrams RA, Grochow LB, et al. (1997) Pancreaticoduodenectomy for pancreatic adenocarcinoma: postoperative adjuvant chemoradiation improves survival. A prospective, single-institution experience. Ann Surg 225(5):621–636CrossRefPubMedPubMedCentral Yeo CJ, Abrams RA, Grochow LB, et al. (1997) Pancreaticoduodenectomy for pancreatic adenocarcinoma: postoperative adjuvant chemoradiation improves survival. A prospective, single-institution experience. Ann Surg 225(5):621–636CrossRefPubMedPubMedCentral
6.
go back to reference Spanknebel K, Conlon KC (2001) Advances in the surgical management of pancreatic cancer. Cancer J 7(4):312–323PubMed Spanknebel K, Conlon KC (2001) Advances in the surgical management of pancreatic cancer. Cancer J 7(4):312–323PubMed
Metadata
Title
Value of pelvis CT during follow-up of patients with pancreatic adenocarcinoma
Authors
Jason J. Bailey
James H. Ellis
Matthew S. Davenport
Richard H. Cohan
Bin Nan
Aishwarya Parameswaran
Lin Hsu
Vaibhav Sahai
Isaac R. Francis
Publication date
01-01-2017
Publisher
Springer US
Published in
Abdominal Radiology / Issue 1/2017
Print ISSN: 2366-004X
Electronic ISSN: 2366-0058
DOI
https://doi.org/10.1007/s00261-016-0869-6

Other articles of this Issue 1/2017

Abdominal Radiology 1/2017 Go to the issue

Classics in Abdominal Imaging

The “starry sky” liver

Classics in Abdominal Imaging

The “eggplant penis” sign

Live Webinar | 27-06-2024 | 18:00 (CEST)

Keynote webinar | Spotlight on medication adherence

Live: Thursday 27th June 2024, 18:00-19:30 (CEST)

WHO estimates that half of all patients worldwide are non-adherent to their prescribed medication. The consequences of poor adherence can be catastrophic, on both the individual and population level.

Join our expert panel to discover why you need to understand the drivers of non-adherence in your patients, and how you can optimize medication adherence in your clinics to drastically improve patient outcomes.

Prof. Kevin Dolgin
Prof. Florian Limbourg
Prof. Anoop Chauhan
Developed by: Springer Medicine
Obesity Clinical Trial Summary

At a glance: The STEP trials

A round-up of the STEP phase 3 clinical trials evaluating semaglutide for weight loss in people with overweight or obesity.

Developed by: Springer Medicine